Adipocyte-Mineralocorticoid Receptor Alters Mitochondrial Quality Control Leading to Mitochondrial Dysfunction and Senescence of Visceral Adipose Tissue.
adipose tissue
metabolic syndrome
mineralocorticoid receptor
mitochondrial dysfunction
oxidative stress
senescence
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
12 Mar 2021
12 Mar 2021
Historique:
received:
30
01
2021
revised:
03
03
2021
accepted:
08
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
21
4
2021
Statut:
epublish
Résumé
Mineralocorticoid receptor (MR) expression is increased in the adipose tissue (AT) of obese patients and animals. We previously demonstrated that adipocyte-MR overexpression in mice (Adipo-MROE mice) is associated with metabolic alterations. Moreover, we showed that MR regulates mitochondrial dysfunction and cellular senescence in the visceral AT of obese db/db mice. Our hypothesis is that adipocyte-MR overactivation triggers mitochondrial dysfunction and cellular senescence, through increased mitochondrial oxidative stress (OS). Using the Adipo-MROE mice with conditional adipocyte-MR expression, we evaluated the specific effects of adipocyte-MR on global and mitochondrial OS, as well as on OS-induced damage. Mitochondrial function was assessed by high throughput respirometry. Molecular mechanisms were probed in AT focusing on mitochondrial quality control and senescence markers. Adipo-MROE mice exhibited increased mitochondrial OS and altered mitochondrial respiration, associated with reduced biogenesis and increased fission. This was associated with OS-induced DNA-damage and AT premature senescence. In conclusion, targeted adipocyte-MR overexpression leads to an imbalance in mitochondrial dynamics and regeneration, to mitochondrial dysfunction and to ageing in visceral AT. These data bring new insights into the MR-dependent AT dysfunction in obesity.
Identifiants
pubmed: 33809055
pii: ijms22062881
doi: 10.3390/ijms22062881
pmc: PMC8001019
pii:
doi:
Substances chimiques
Receptors, Mineralocorticoid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agence Nationale de la Recherche
ID : ANR-15- RHUS-0003
Organisme : Fondation de France
ID : CARDIO 00086498
Organisme : Institut National de la Santé et de la Recherche Médicale
ID : operating budget
Organisme : Institut National de la Santé et de la Recherche Médicale
ID : poste d'accueil
Organisme : Wenner-Gren Foundation
Organisme : Magnus Bergvalls Stiftelse
Organisme : Åke Wiberg Stiftelse
Références
Hypertension. 2012 May;59(5):1069-78
pubmed: 22493070
Physiol Rev. 2013 Jul;93(3):1139-206
pubmed: 23899562
Endocrinology. 2020 Feb 1;161(2):
pubmed: 32036385
Am J Physiol Renal Physiol. 2007 Oct;293(4):F1065-71
pubmed: 17670905
Oxid Med Cell Longev. 2010 Mar-Apr;3(2):77-85
pubmed: 20716932
Hypertension. 2015 Jul;66(1):158-66
pubmed: 25987661
Curr Opin Endocrinol Diabetes Obes. 2012 Jun;19(3):168-75
pubmed: 22499218
Hypertens Res. 2016 Mar;39(3):133-7
pubmed: 26606875
Sci Rep. 2018 May 1;8(1):6801
pubmed: 29717226
Obesity (Silver Spring). 2010 May;18(5):897-903
pubmed: 19876011
Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50
pubmed: 19358089
Redox Biol. 2015;4:6-13
pubmed: 25479550
Sci Rep. 2017 Dec 1;7(1):16802
pubmed: 29196758
Metabolism. 2008 Aug;57(8):1071-7
pubmed: 18640384
Cell Tissue Res. 2012 Apr;348(1):71-80
pubmed: 22331364
Circulation. 2015 Dec 1;132(22):2134-45
pubmed: 26362633
Diabetes Obes Metab. 2014 Mar;16(3):268-72
pubmed: 24125483
Oxid Med Cell Longev. 2014;2014:908539
pubmed: 25143800
Obesity (Silver Spring). 2017 Apr;25(4):704-712
pubmed: 28240819
Cell Rep. 2016 Sep 13;16(11):2991-3002
pubmed: 27626667
Am J Physiol Endocrinol Metab. 2014 Aug 1;307(3):E262-77
pubmed: 24918202
Trends Endocrinol Metab. 2008 Apr;19(3):88-90
pubmed: 18314347
Hypertension. 2019 Feb;73(2):458-468
pubmed: 30624990
Hypertension. 2015 Jul;66(1):149-57
pubmed: 25966493
Trends Endocrinol Metab. 2020 Mar;31(3):205-217
pubmed: 31843490
Curr Hypertens Rep. 2010 Aug;12(4):252-7
pubmed: 20563672
Am J Physiol Renal Physiol. 2007 Sep;293(3):F723-31
pubmed: 17596522
Diabetes. 2016 Aug;65(8):2392-403
pubmed: 27207514
Circulation. 2008 Apr 29;117(17):2253-61
pubmed: 18427128
Diabetes Obes Metab. 2019 Oct;21(10):2305-2314
pubmed: 31183945
Hypertension. 2017 May;69(5):870-878
pubmed: 28320854
Essays Biochem. 2010;47:69-84
pubmed: 20533901
Trends Endocrinol Metab. 2000 Oct;11(8):327-32
pubmed: 10996528
Molecules. 2017 Jan 21;22(1):
pubmed: 28117726
Endocrinology. 2011 Feb;152(2):680-8
pubmed: 21190955
J Endocrinol. 2016 Nov;231(2):R61-R75
pubmed: 27613337
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14211-6
pubmed: 14614137
Diabetes. 2021 Jan;70(1):196-203
pubmed: 33055188
J Clin Endocrinol Metab. 2010 Aug;95(8):4037-42
pubmed: 20484481
Diabetologia. 2006 Apr;49(4):784-91
pubmed: 16501941
Biol Chem. 2010 Nov;391(11):1265-79
pubmed: 20868230
Hypertens Res. 2009 Aug;32(8):649-57
pubmed: 19521418
Exp Diabetes Res. 2012;2012:642038
pubmed: 22203837
Endocrinology. 2014 Nov;155(11):4461-72
pubmed: 25051445
Biochim Biophys Acta. 2012 Oct;1817(10):1833-8
pubmed: 22409868
Science. 2005 Jan 21;307(5708):384-7
pubmed: 15662004
Nat Med. 2009 Sep;15(9):1082-7
pubmed: 19718037
Am J Physiol Renal Physiol. 2018 May 1;314(5):F798-F808
pubmed: 28659272
PLoS One. 2016 Jan 05;11(1):e0145946
pubmed: 26730742
Mol Cell Biochem. 2015 Jan;399(1-2):95-103
pubmed: 25312902
J Clin Endocrinol Metab. 2006 Feb;91(2):454-9
pubmed: 16291704
Toxicol Appl Pharmacol. 2014 Nov 1;280(3):399-407
pubmed: 25204689
Endocrinology. 2015 Mar;156(3):923-33
pubmed: 25549046
Aging Cell. 2008 Jan;7(1):101-11
pubmed: 18031569
Life Sci. 2018 Jan 1;192:26-32
pubmed: 29155300
Free Radic Biol Med. 2012 Jul 1;53(1):30-43
pubmed: 22608985
J Physiol. 2010 Jun 15;588(Pt 12):2023-32
pubmed: 20421291
Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):446-52
pubmed: 20585248
Sci Rep. 2018 Dec 3;8(1):17547
pubmed: 30510203
Curr Opin Nephrol Hypertens. 2018 Mar;27(2):63-69
pubmed: 29135585
Cell Metab. 2012 Dec 5;16(6):765-76
pubmed: 23168219
Front Pharmacol. 2018 Mar 09;9:176
pubmed: 29593530
Biochim Biophys Acta. 2009 May;1787(5):414-20
pubmed: 19007744
Trends Endocrinol Metab. 2009 Nov;20(9):444-51
pubmed: 19800255
Antioxid Redox Signal. 2014 Feb 1;20(4):727-31
pubmed: 24159899
J Clin Endocrinol Metab. 2006 Sep;91(9):3457-63
pubmed: 16822818
Cardiovasc Res. 2009 Oct 1;84(1):164-72
pubmed: 19505930
Biochem Biophys Res Commun. 2018 Jun 7;500(3):682-690
pubmed: 29678576
Horm Metab Res. 2012 Mar;44(3):208-14
pubmed: 22116746
Hypertension. 2012 May;59(5):966-72
pubmed: 22469622
J Clin Invest. 2004 Dec;114(12):1752-61
pubmed: 15599400
Am J Pathol. 2011 May;178(5):2020-31
pubmed: 21514419